Cargando…
Interferon Therapy Exacerbated Pulmonary Hypertension in a Patient with Hepatitis C Virus Infection: Pathogenic Interplay among Multiple Risk Factors
Pulmonary arterial hypertension (PAH) is known to develop as a consequence of multiple genetic and/or non-genetic factors. A 27-year-old woman with chronic hepatitis C virus (HCV) infection developed severe PAH after interferon (IFN) therapy. Although most of the reported clinical courses of IFN-ind...
Autores principales: | Tsuchiya, Hiromi, Kioka, Hidetaka, Ozu, Kentaro, Ohtani, Tomohito, Yamaguchi, Osamu, Yazaki, Yoshikazu, Yamauchi-Takihara, Keiko, Sakata, Yasushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478568/ https://www.ncbi.nlm.nih.gov/pubmed/28458313 http://dx.doi.org/10.2169/internalmedicine.56.7822 |
Ejemplares similares
-
Successful treatment of severe combined post- and pre-capillary pulmonary hypertension in a patient with idiopathic restrictive cardiomyopathy
por: Ishihara, Satomi, et al.
Publicado: (2018) -
Alpha-Klotho is a novel predictor of treatment responsiveness in patients with heart failure
por: Taneike, Manabu, et al.
Publicado: (2021) -
Polycythemia Vera Associated with Pulmonary Hypertension and Diffuse Large B-Cell Lymphoma: A Case Report
por: Kameda, Satoshi, et al.
Publicado: (2021) -
Long-term Effects of the Janus Kinase 1/2 Inhibitor Ruxolitinib on Pulmonary Hypertension and the Cardiac Function in a Patient with Myelofibrosis
por: Miyawaki, Hiroshi, et al.
Publicado: (2019) -
First Report of Electromagnetic Interference Between Percutaneous Ventricular Assist Device and Implantable Cardioverter-Defibrillator
por: Takahari, Kosuke, et al.
Publicado: (2023)